查找临床试验
已按「杜氏肌营养不良」检索，对应国际通用词 Duchenne muscular dystrophy
共找到 63 项正在招募的试验
数据更新于 00:19，每 5 分钟自动同步A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.
China
年龄 4 Years – 9 Years
Belief BioMed (Beijing) Co., Ltd
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
United States、Belgium、Canada、France、Germany 等 11 国
年龄 7 Years – 不限
Italfarmaco
A Remote Study Using Technology to Assess Outcomes in DMD
United Kingdom
年龄 1 Year – 3 Years
University of Oxford
Biomarker Development for Muscular Dystrophies
United States
年龄 5 Years – 不限
Massachusetts General Hospital
A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therapy in Pediatric Patients With Duchenne Muscular Dystrophy
Belarus、Russia
年龄 4 Years – 9 Years
AO GENERIUM
Urinary Titin Biomarker in DMD
United States
年龄 2 Years – 10 Years
Children's Hospital of Philadelphia
DMD Gene Variants and Cardiac Dysfunction in Young Males With Dystrophinopathies
Greece
年龄 2 Years – 24 Years
Aristotle University Of Thessaloniki
Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
United States
年龄 8 Years – 18 Years
Vanderbilt University Medical Center
Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients
United States
年龄 6 Years – 不限
University of Florida
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
United States、Canada、Italy、United Kingdom
年龄 0 Years – 17 Years
Solid Biosciences Inc.
Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
United States
年龄 5 Years – 不限
Columbia University
A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
United States
年龄 6 Years – 不限
ITF Therapeutics LLC